Skip to content
healthcare.dev

dasatinib

NDC 70771-1906, dasatinib, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1906
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218719
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1906 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DASATINIB140 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
70771-1906-37077119060330 TABLET in 1 BOTTLE (70771-1906-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4eed6b7b-a09d-4d2e-a345-968dd68323bc

Use it

Look up 70771-1906 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1906 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1906. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.